165 related articles for article (PubMed ID: 37032077)
21. Utility of volumetric contrast-enhanced and diffusion-weighted MRI in differentiating between common primary hypervascular liver tumors.
Zarghampour M; Fouladi DF; Pandey A; Ghasabeh MA; Pandey P; Varzaneh FN; Khoshpouri P; Shao N; Pan L; Grimm R; Kamel IR
J Magn Reson Imaging; 2018 Oct; 48(4):1080-1090. PubMed ID: 29630756
[TBL] [Abstract][Full Text] [Related]
22. Liver contrast-enhanced sonography: computer-assisted differentiation between focal nodular hyperplasia and inflammatory hepatocellular adenoma by reference to microbubble transport patterns.
Denis de Senneville B; Frulio N; Laumonier H; Salut C; Lafitte L; Trillaud H
Eur Radiol; 2020 May; 30(5):2995-3003. PubMed ID: 32002637
[TBL] [Abstract][Full Text] [Related]
23. Primary hepatocellular lesions: imaging findings on state-of-the-art magnetic resonance imaging, with pathologic correlation.
van den Bos IC; Hussain SM; de Man RA; Zondervan PE; Ijzermans JN; Krestin GP
Curr Probl Diagn Radiol; 2008; 37(3):104-14. PubMed ID: 18436110
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory hepatocellular adenomas can mimic focal nodular hyperplasia on gadoxetic acid-enhanced MRI.
Agarwal S; Fuentes-Orrego JM; Arnason T; Misdraji J; Jhaveri KS; Harisinghani M; Hahn PF
AJR Am J Roentgenol; 2014 Oct; 203(4):W408-14. PubMed ID: 25055198
[TBL] [Abstract][Full Text] [Related]
25. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
[TBL] [Abstract][Full Text] [Related]
26. Fat in mass in primary liver lesions: are usual MRI diagnostic criteria of both malignant and benign liver lesions still applicable?
Reizine E; Meurgey A; Amaddeo G; Laurent A; Calderaro J; Mule S; Luciani A
Abdom Radiol (NY); 2022 Jul; 47(7):2347-2355. PubMed ID: 35672475
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic utility and limitations of glutamine synthetase and serum amyloid-associated protein immunohistochemistry in the distinction of focal nodular hyperplasia and inflammatory hepatocellular adenoma.
Joseph NM; Ferrell LD; Jain D; Torbenson MS; Wu TT; Yeh MM; Kakar S
Mod Pathol; 2014 Jan; 27(1):62-72. PubMed ID: 23807780
[TBL] [Abstract][Full Text] [Related]
28. Hepatic adenoma and focal nodular hyperplasia.
Shortell CK; Schwartz SI
Surg Gynecol Obstet; 1991 Nov; 173(5):426-31. PubMed ID: 1658955
[TBL] [Abstract][Full Text] [Related]
29. Contrast-enhanced ultrasound in combination with color Doppler ultrasound can improve the diagnostic performance of focal nodular hyperplasia and hepatocellular adenoma.
Kong WT; Wang WP; Huang BJ; Ding H; Mao F; Si Q
Ultrasound Med Biol; 2015 Apr; 41(4):944-51. PubMed ID: 25701530
[TBL] [Abstract][Full Text] [Related]
30. Differentiating focal nodular hyperplasia from hepatocellular adenoma: Is hepatobiliary phase MRI (HBP-MRI) using linear gadolinium chelates always useful?
Roux M; Pigneur F; Baranes L; Calderaro J; Chiaradia M; Decaens T; Kastahian S; Charles-Nelson A; Tselikas L; Costentin C; Laurent A; Azoulay D; Mallat A; Rahmouni A; Luciani A
Abdom Radiol (NY); 2018 Jul; 43(7):1670-1681. PubMed ID: 29110059
[TBL] [Abstract][Full Text] [Related]
31. Quantitative correlation between uptake of Gd-BOPTA on hepatobiliary phase and tumor molecular features in patients with benign hepatocellular lesions.
Reizine E; Amaddeo G; Pigneur F; Baranes L; Legou F; Mulé S; Zegai B; Roche V; Laurent A; Rahmouni A; Calderaro J; Luciani A
Eur Radiol; 2018 Oct; 28(10):4243-4253. PubMed ID: 29721686
[TBL] [Abstract][Full Text] [Related]
32. Hepatocellular carcinoma and focal nodular hyperplasia in patients with Fontan-associated liver disease: characterisation using dynamic gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced MRI.
Shiina Y; Inai K; Sakai R; Tokushige K; Nagao M
Clin Radiol; 2023 Mar; 78(3):e197-e203. PubMed ID: 36481111
[TBL] [Abstract][Full Text] [Related]
33. Washout appearance in Gd-EOB-DTPA-enhanced MR imaging: A differentiating feature between hepatocellular carcinoma with paradoxical uptake on the hepatobiliary phase and focal nodular hyperplasia-like nodules.
Kim JW; Lee CH; Kim SB; Park BN; Park YS; Lee J; Park CM
J Magn Reson Imaging; 2017 Jun; 45(6):1599-1608. PubMed ID: 27726242
[TBL] [Abstract][Full Text] [Related]
34. [A rare form of benign tumor of the liver possibly related to the use of oral contraceptives: focal pediculated nodular hyperplasia].
Brouquet J; Chameaud J; Vire O; Fabre P; Catanzano G; Baudet JH
Rev Fr Gynecol Obstet; 1985; 80(8-9):621-7. PubMed ID: 2997901
[TBL] [Abstract][Full Text] [Related]
35. Intrapatient Comparison of the Hepatobiliary Phase of Gd-BOPTA and Gd-EOB-DTPA in the Differentiation of Hepatocellular Adenoma From Focal Nodular Hyperplasia.
Vanhooymissen IJSML; Thomeer MG; Braun LMM; Gest B; van Koeverden S; Willemssen FE; Hunink M; De Man RA; Ijzermans JN; Dwarkasing RS
J Magn Reson Imaging; 2019 Mar; 49(3):700-710. PubMed ID: 30252977
[TBL] [Abstract][Full Text] [Related]
36. Retrospective analysis of 29 patients surgically treated for hepatocellular adenoma or focal nodular hyperplasia.
Closset J; Veys I; Peny MO; Braude P; Van Gansbeke D; Lambilliotte JP; Gelin M
Hepatogastroenterology; 2000; 47(35):1382-4. PubMed ID: 11100357
[TBL] [Abstract][Full Text] [Related]
37. MR imaging features for improved diagnosis of hepatocellular carcinoma in the non-cirrhotic liver: Multi-center evaluation.
Fischer MA; Raptis DA; Donati OF; Hunziker R; Schade E; Sotiropoulos GC; McCall J; Bartlett A; Bachellier P; Frilling A; Breitenstein S; Clavien PA; Alkadhi H; Patak MA
Eur J Radiol; 2015 Oct; 84(10):1879-87. PubMed ID: 26194029
[TBL] [Abstract][Full Text] [Related]
38. A Model-Based Prediction of the Probability of Hepatocellular Adenoma and Focal Nodular Hyperplasia Based on Characteristics on Contrast-Enhanced Ultrasound.
Taimr P; Bröker MEE; Dwarkasing RS; Hansen BE; de Knegt RJ; De Man RA; IJzermans JNM
Ultrasound Med Biol; 2017 Oct; 43(10):2144-2150. PubMed ID: 28743375
[TBL] [Abstract][Full Text] [Related]
39. Focal nodular hyperplasia-like nodule with reduced expression of organic anion transporter 1B3 in alcoholic liver cirrhosis.
Doi N; Tomiyama Y; Kawase T; Nishina S; Yoshioka N; Hara Y; Yoshida K; Korenaga K; Korenaga M; Moriya T; Urakami A; Nakashima O; Kojiro M; Hino K
Intern Med; 2011; 50(11):1193-9. PubMed ID: 21628934
[TBL] [Abstract][Full Text] [Related]
40. Efficacy comparison of multi-phase CT and hepatotropic contrast-enhanced MRI in the differential diagnosis of focal nodular hyperplasia: a prospective cohort study.
Nowicki TK; Markiet K; Izycka-Swieszewska E; Dziadziuszko K; Studniarek M; Szurowska E
BMC Gastroenterol; 2018 Jan; 18(1):10. PubMed ID: 29334905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
